FIRST FINANCIAL CORP /IN/ Discloses Q4 2023 Holdings

TL;DR

**FIRST FINANCIAL CORP /IN/ just dropped its Q4 holdings, showing big bets on pharma giants like Abbott and AbbVie!**

AI Summary

FIRST FINANCIAL CORP /IN/ (FFBC) filed its 13F-HR on January 16, 2024, revealing its holdings as of December 31, 2023. The filing shows significant sole voting power in companies like ABBOTT LABS, with 19,385 shares valued at $2,140,272, and ABBVIE INC, with 15,318 shares valued at $2,373,817. This matters to investors because it provides transparency into the investment strategy of a major financial institution, indicating their confidence in specific sectors and companies, which can influence market sentiment and potentially the stock's performance.

Why It Matters

This filing offers a glimpse into the investment decisions of a significant financial institution, potentially signaling trends or confidence in certain stocks that individual investors might consider for their own portfolios.

Risk Assessment

Risk Level: low — 13F filings are backward-looking disclosures of holdings, providing transparency without indicating immediate future risks.

Analyst Insight

Investors should review the specific holdings to understand the types of companies and sectors FIRST FINANCIAL CORP /IN/ is investing in, potentially using this information to inform their own portfolio diversification or sector focus.

Key Numbers

• $2.14M — Value of ABBOTT LABS shares (Represents a significant investment by FIRST FINANCIAL CORP /IN/ as of December 31, 2023.)
• 19,445 — Total shares of ABBOTT LABS (Indicates the total number of shares held, with 19,385 under sole voting power.)
• $2.37M — Value of ABBVIE INC shares (Highlights another substantial holding by FIRST FINANCIAL CORP /IN/ as of December 31, 2023.)
• 15,318 — Total shares of ABBVIE INC (Shows the total number of shares held, all under sole voting power.)
• 20231231 — Conformed Period of Report (This is the date the reported holdings are accurate as of, providing a snapshot of the portfolio at year-end.)

Key Players & Entities

• FIRST FINANCIAL CORP /IN/ (company) — filer of the 13F-HR
• Jennifer Hanley (person) — Trust Operations Manager for FIRST FINANCIAL CORP /IN/
• ABBOTT LABS (company) — a significant holding of FIRST FINANCIAL CORP /IN/
• ABBVIE INC (company) — a significant holding of FIRST FINANCIAL CORP /IN/
• $2,140,272 (dollar_amount) — value of ABBOTT LABS shares held
• $2,373,817 (dollar_amount) — value of ABBVIE INC shares held

Forward-Looking Statements

• FIRST FINANCIAL CORP /IN/ will maintain its significant positions in pharmaceutical companies like Abbott Labs and AbbVie in its next 13F filing. (FIRST FINANCIAL CORP /IN/) — medium confidence, target: 2024-03-31

FAQ

Filing Documents

• primary_doc.html (13F-HR)
• primary_doc.xml (13F-HR) — 2KB
• infotable.html (INFORMATION TABLE)
• infotable.xml (INFORMATION TABLE) — 228KB
• 0001104659-24-003938.txt ( ) — 231KB

From the Filing

SEC FORM 13F-HR The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. The reader should not assume that the information is accurate and complete. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F COVER PAGE OMB APPROVAL OMB Number: 3235-0006 Estimated average burden hours per response: 23.8 Report for the Calendar Year or Quarter Ended: 12-31-2023 Check here if Amendment    Amendment Number: This Amendment (Check only one.):    is a restatement.    adds new holdings entries. Institutional Investment Manager Filing this Report: Name: FIRST FINANCIAL CORP /IN/ Address: One First Financial Plaza Terre Haute , IN   47807 Form 13F File Number: 028-14510 CRD Number (if applicable): The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: JENNIFER HANLEY Title: TRUST OPERATIONS MANANGER Phone: 812-238-6216 Signature, Place, and Date of Signing: Jennifer L Hanley Terre Haute ,  IN 01-09-2024 [Signature] [City, State] [Date] Report Type (Check only one.): X 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)    13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)    13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) Form 13F Summary Page Report Summary: Number of Other Included Managers: 0 Form 13F Information Table Entry Total: 501 Form 13F Information Table Value Total: 196,536,095 (round to nearest dollar) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. [If there are no entries in this list, state “NONE” and omit the column headings and list entries.] NONE

View Full Filing

View this 13F-HR filing on SEC EDGAR